StonvexLoading…
StonvexCore line items from BKKT's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $2.34B | $3.44B | $726.99M | $56.22M |
Operating Income | $-147.84M | $-82.59M | $-156.24M | $-2.02B |
Net Income | $-107.21M | $-46.66M | $-74.85M | $-578.11M |
EPS (Diluted) | $-8.87 | $-7.97 | $-21.01 | $-203.08 |
Total Assets | $162.79M | $269.38M | $265.31M | $455.50M |
Total Liabilities | $50.01M | $206.52M | $129.60M | $119.43M |
Cash & Equivalents | $26.96M | $39.05M | $52.88M | $98.33M |
Free Cash Flow OCF − CapEx | Not available | $-24.29M | $-70.13M | $-148.14M |
Shares Outstanding | 12.09M | 5.86M | 3.56M | 2.85M |